Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway
Authors
Keywords
Transcription factors, Phosphorylation, Endothelial cells, Protein expression, Small interfering RNAs, Flow cytometry, In vivo imaging, Lipoproteins
Journal
PLoS One
Volume 11, Issue 1, Pages e0146777
Publisher
Public Library of Science (PLoS)
Online
2016-01-12
DOI
10.1371/journal.pone.0146777
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bidirectional Regulation of Nuclear Factor-κB and Mammalian Target of Rapamycin Signaling Functionally Links Bnip3 Gene Repression and Cell Survival of Ventricular Myocytes
- (2013) Rimpy Dhingra et al. Circulation-Heart Failure
- Targeting the NF- B and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKK for Pancreas Cancer Therapy
- (2013) P. Radhakrishnan et al. CLINICAL CANCER RESEARCH
- Insulin Stimulates Mitochondrial Fusion and Function in Cardiomyocytes via the Akt-mTOR-NF B-Opa-1 Signaling Pathway
- (2013) V. Parra et al. DIABETES
- mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells
- (2013) F Guo et al. LEUKEMIA
- The Effect of mTOR-Inhibition on NF-κB Activity in Kidney Ischemia-Reperfusion Injury in Mice
- (2013) A. Kezic et al. TRANSPLANTATION PROCEEDINGS
- LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
- (2012) Suowen Xu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- LOX-1
- (2012) Tatsuya Sawamura et al. CURRENT OPINION IN LIPIDOLOGY
- Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis
- (2012) Hiroyuki Itabe JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Glutamine modulates lipopolysaccharide-induced activation of NF-κB via the Akt/mTOR pathway in lung epithelial cells
- (2011) Yu-Chen Hou et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells
- (2011) Ping Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-κB
- (2010) Parvaneh Rafiee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The autophagy-lysosome pathway: A novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells
- (2010) Yan-lin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE−/− mouse model
- (2010) Stephen J. White et al. CARDIOVASCULAR PATHOLOGY
- Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells
- (2010) Mansoor Ahmed et al. Molecular Cancer
- Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
- (2009) Wen Qiang Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Everolimus Inhibits Monocyte/Macrophage Migration in Vitro and Their Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits
- (2008) R. Baetta et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR−/− mice despite severe hypercholesterolemia
- (2007) Marc A. Mueller et al. ATHEROSCLEROSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started